Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie (prior sponsor, Abbott)
Age
45–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with mixed dyslipidemia
Qualifying cIMT thickness
You may not be if
Patients with certain chronic or unstable medical conditions.
Patients with unstable dose of medications or receiving coumadin, cyclosporine, or certain other medications
Pregnant or lactating women or women intending to become pregnant
Patients with diabetes mellitus that is poorly controlled
Clareo Health | Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
